Stimulant drugs
Abstract
Stimulants are a key element in the treatment of ADHD. Carefully designed trials of stimulants have found substantial improvement in ADHD core behaviours in 65-75 % of subjects with ADHD. Most standard stimulants are rapidly absorbed, with their behavioural effects appearing within 30 minutes, reaching a peak within one to three hours and disappearing within five hours. Doses at school are often necessary, in spite of the risk of peer ridicule and added adult supervision requirements. The mechanism by which stimulants act to reduce hyperactivity is not completely understood, but they improve impulsivity and activity levels. Several controlled evaluations made over periods of time greater than a year show a clear persistence of medication effects over time. A carefully crafted programme of treatment with methylphenidate is more effective in the reduction of hyperactivity symptoms than an intensive programme of behavioural and cognitive intervention. The combination of stimulants with psychosocial interventions in ADHD offers few advantages over medication alone. Unchallengeable guides to practice that would be appropriate everywhere are difficult to propose. It is imperative that clinicians prescribing stimulants should monitor the use of the drug properly, making sure that it is not being abused by the child's family, peers or those dispensing medication at school. Polypharmacy should only be embarked on by a specialist service and the combination of methylphenidate and cloni…
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
Longitudinal studies on ADHD patients reported age-dependent amelioration of symptoms of hyperactivity, and those adults may develop hypo-responsiveness or resistance to psychostimulants induced by specified developmental trajectories.
“Longitudinal studies on ADHD patients reported age-dependent amelioration of symptoms of hyperactivity, and those adults may develop hypo-responsiveness or resistance to psychostimulants induced by specified developmental trajectories”
From Overlapping and differential neuropharmacological mechanisms of stimulants and nonstimulants for attention-deficit/hyperactivity disorder: A comparative neuroimaging analysis (2024) · cites this paper as Santosh & Taylor, 2000
No citation lists for this paper
No citation lists for this paper yet — checked again daily.
References 110 · Cited by 94
- Authors
- Santosh, P. J., & Taylor, E.
- Venue
- European Child & Adolescent Psychiatry
- Published
- 2000-03
- Volume
- 9
- Issue
- S1
- Pages
- S27-S43
- ISSN
- 1018-8827 (ISSN-L)
- 1435-165X
- OpenAlex
- W4211216202
- Cited by
- 94
- References
- 110
- Citations by year
- 2025: 4 · 2024: 2 · 2023: 13 · 2021: 6 · 2020: 2 · 2019: 1 · 2018: 1 · 2016: 4 · 2015: 2 · 2014: 3 · 2013: 5 · 2012: 3
- FWCI
- 0.62
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- European Child & Adolescent Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Research Portal (King's College London) (submittedVersion)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Attention Deficit Hyperactivity Disorder
- Social Sciences › Psychology › Developmental and Educational Psychology › Behavioral and Psychological Studies
- Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
- Keywords
- stimulants, attention deficit hyperactivity disorder, methylphenidate, clonidine, hyperactivity, impulsivity, polypharmacy, substance abuse risk, pharmacokinetics, pharmacodynamics, pharmacogenetics, narcolepsy, treatment-resistant depression, psychosocial interventions, elementary school students
- MeSH terms
- Adolescent, Central Nervous System Stimulants, Feeding and Eating Disorders, Attention Deficit Disorder with Hyperactivity, Child, Child Psychiatry, Child, Preschool, Combined Modality Therapy, Cost-Benefit Analysis, Drug Therapy, Combination, Female, Humans, Male, Psychotherapy, Drug Costs, Practice Guidelines as Topic, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review